ATRX and neoplasm: For PNOC009-5 immunohistochemistry supported the diagnosis of DMG, demonstrating diffuse H3 K27M positivity in tumor nuclei and loss of H3 K27me3 staining in neoplastic nuclei, negative for IDH-1 mutant protein, retained ATRX expression in tumor nuclei, and negative p53.